Observational studyJournal for immunotherapy of cancer2025

Classification of patients with relapsed/refractory large B-cell lymphoma who do not develop early CRS/NE toxicity using ZUMA clinical trial data.

Kelly Speth et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.